These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29471762)

  • 1. Impact of cocaine use on protease inhibitor-associated dyslipidemia in HIV-infected adults.
    Li J; Lai H; Chen S; Lai S
    Int J STD AIDS; 2018 Jul; 29(8):781-789. PubMed ID: 29471762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid profiles of Thai adult HIV-infected patients receiving protease inhibitors.
    Hiransuthikul N; Hiransuthikul P; Kanasook Y
    Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):69-77. PubMed ID: 17539249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study.
    McComsey G; Bhumbra N; Ma JF; Rathore M; Alvarez A;
    Pediatrics; 2003 Mar; 111(3):e275-81. PubMed ID: 12612284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked dyslipidemia in human immunodeficiency virus-infected children on protease inhibitor-containing antiretroviral therapy.
    Lainka E; Oezbek S; Falck M; Ndagijimana J; Niehues T
    Pediatrics; 2002 Nov; 110(5):e56. PubMed ID: 12415062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative effects of insulin resistance and protease inhibitor treatment on lipid and lipoprotein metabolism in HIV-infected patients.
    Beatty G; Chu J; Kulkarni K; Lipshutz G; Khalili M; Abbasi F; Stansell J; Reaven GM
    HIV Clin Trials; 2004; 5(6):383-91. PubMed ID: 15682351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-Term Efficacy and Safety of Adding Ezetimibe to Current Regimen of Lipid-Lowering Drugs in Human Immunodeficiency Virus-Infected Thai Patients Treated with Protease Inhibitors.
    Boonthos K; Puttilerpong C; Pengsuparp T; Manosuthi W
    Jpn J Infect Dis; 2018 May; 71(3):220-224. PubMed ID: 29709973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyslipidaemia and insulin resistance in vertically HIV-infected children and adolescents.
    dos Reis LC; de Carvalho Rondó PH; de Sousa Marques HH; de Andrade SB
    Trans R Soc Trop Med Hyg; 2011 Apr; 105(4):197-203. PubMed ID: 21371728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral treatment associated hyperglycemia and dyslipidemia among HIV infected patients at Burayu Health Center, Addis Ababa, Ethiopia: a cross-sectional comparative study.
    Abebe M; Kinde S; Belay G; Gebreegziabxier A; Challa F; Gebeyehu T; Nigussie P; Tegbaru B
    BMC Res Notes; 2014 Jun; 7():380. PubMed ID: 24950924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy.
    Egaña-Gorroño L; Martínez E; Cormand B; Escribà T; Gatell J; Arnedo M
    AIDS; 2013 Feb; 27(4):529-38. PubMed ID: 23262498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of dyslipidaemia among HIV-infected patients receiving combination antiretroviral therapy in North Shewa, Ethiopia.
    Fiseha T; Alemu W; Dereje H; Tamir Z; Gebreweld A
    PLoS One; 2021; 16(4):e0250328. PubMed ID: 33905435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipids profile among ART-naïve HIV infected patients and men who have sex with men in China: a case control study.
    Wang Q; Ding H; Xu J; Geng W; Liu J; Guo X; Kang J; Li X; Jiang Y; Shang H
    Lipids Health Dis; 2016 Sep; 15(1):149. PubMed ID: 27600391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men.
    Floris-Moore M; Howard AA; Lo Y; Schoenbaum EE; Arnsten JH; Klein RS
    AIDS Patient Care STDS; 2007 Jul; 21(7):479-91. PubMed ID: 17651029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid profile changes by high activity anti-retroviral therapy.
    Duro M; Sarmento-Castro R; Almeida C; Medeiros R; Rebelo I
    Clin Biochem; 2013 Jun; 46(9):740-4. PubMed ID: 23295258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary artery calcification, atherogenic lipid changes, and increased erythrocyte volume in black injection drug users infected with human immunodeficiency virus-1 treated with protease inhibitors.
    Meng Q; Lima JA; Lai H; Vlahov D; Celentano DD; Strathdee SA; Nelson KE; Wu KC; Chen S; Tong W; Lai S
    Am Heart J; 2002 Oct; 144(4):642-8. PubMed ID: 12360160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon.
    Nsagha DS; Weledji EP; Assob NJ; Njunda LA; Tanue EA; Kibu OD; Ayima CW; Ngowe MN
    BMC Cardiovasc Disord; 2015 Aug; 15():95. PubMed ID: 26315756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment.
    Rose H; Woolley I; Hoy J; Dart A; Bryant B; Mijch A; Sviridov D
    Metabolism; 2006 Jan; 55(1):90-5. PubMed ID: 16324925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Lipid Indices in HIV+ Cases on HAART.
    Ji S; Xu Y; Han D; Peng X; Lu X; Brockmeyer NH; Wu N
    Biomed Res Int; 2019; 2019():2870647. PubMed ID: 30868068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocaine use modifies the association between antiretroviral therapy and endothelial dysfunction among adults with HIV infection.
    Li J; Lai H; Chen S; Kickler T; Lai S
    J Med Virol; 2019 Sep; 91(9):1660-1667. PubMed ID: 31144332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine.
    Negredo E; Ribalta J; Paredes R; Ferré R; Sirera G; Ruiz L; Salazar J; Reiss P; Masana L; Clotet B
    AIDS; 2002 Jul; 16(10):1383-9. PubMed ID: 12131215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus.
    Nguyen ST; Eaton SA; Bain AM; Rahman AP; Payne KD; Bedimo R; Herrington JD; Maclayton DO; Rodriguez-Barradas MC; Busti AJ
    Pharmacotherapy; 2008 Mar; 28(3):323-30. PubMed ID: 18294112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.